top of page


Innovators. Dreamers.

MedilaboRFP is a clinical stage biotechnology company driven by cutting-edge ideas and science, based on the compassion in patients with neurodegenerative diseases. At medilabo RFP, we understand a tremendous social and personal costs from the burden and we believe that it can be only solved by preventing the deterioration before it gets progressed. Founded by an award winning entrepreneur/scientist and a world renown dementia specialist, Medilabo has spared no effort to improve the lives of our patient's by developing medicines with an already proven safe and efficient antibiotic, rifampicin and is confident in delivering eye-opening, innovative medicines to millions of current and future patients worldwide 

Get in touch today to learn more about the Medilabo RFP story.

Screen Shot 2022-09-11 at 10.43.59
Screen Shot 2022-09-11 at 10.42.17
Screen Shot 2022-09-11 at 10.33.15
Screen Shot 2022-09-11 at 10.37.23
Screen Shot 2022-09-11 at 10.36.08
Screen Shot 2022-09-11 at 10.34.23
bottom of page